Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring
{{output}}
Drug-induced liver injury (DILI) is an important but often underrecognized complication in the management of inflammatory bowel disease (IBD), particularly in patients receiving long-term immunomodulatory or biologic therapies. Agents such as thiopurines, meth... ...
